First Premier Bank Amgen Inc Transaction History

First Premier Bank

$378 Million
Q1 2024

A detailed history of First Premier Bank transactions in Amgen Inc stock. As of the latest transaction made, First Premier Bank holds 9,614 shares of AMGN stock, worth $2.99 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

9,614

Previous 9,724 1.13%

Holding current value

$2.99 Million

Previous $2.8 Million 2.43%

% of portfolio

0.72%

Previous 0.79%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $29,575 - $35,701	-110 Reduced 1.13%	9,614 $2.73 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $25,058 - $28,269	-98 Reduced 1.0%	9,724 $2.8 Million
Q3 2023 Oct 16, 2023	SELL	$218.65 - $271.46 $47,884 - $59,449	-219 Reduced 2.18%	9,822 $2.64 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $53,567 - $63,342	-250 Reduced 2.43%	10,041 $2.23 Million
Q1 2023 Apr 10, 2023	SELL	$225.79 - $275.2 $48,544 - $59,168	-215 Reduced 2.05%	10,291 $2.49 Million

Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $8,474 - $10,767	-37 Reduced 0.35%	10,506 $2.76 Million
Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $9,651 - $10,885	43 Added 0.41%	10,543 $2.38 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.28%	10,500 $2.56 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $43,854 - $48,514	200 Added 1.94%	10,530 $2.55 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $14,916 - $17,070	75 Added 0.73%	10,330 $2.32 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $146,221 - $162,221	626 Added 6.5%	10,255 $2.5 Million
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $52,363 - $62,356	-242 Reduced 2.45%	9,629 $2.21 Million
Q2 2020 Jul 07, 2020	BUY	$197.81 - $242.74 $44,507 - $54,616	225 Added 2.33%	9,871 $2.33 Million
Q1 2020 Apr 08, 2020	BUY	$182.24 - $241.7 $4,738 - $6,284	26 Added 0.27%	9,646 $1.96 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $19,152 - $22,948	110 Added 1.16%	9,620 $1.86 Million
Q1 2019 Apr 04, 2019	SELL	$180.87 - $203.88 $10,852 - $12,232	-60 Reduced 0.63%	9,510 $1.81 Million
Q4 2018 Jan 14, 2019	BUY	$178.4 - $208.25 $21,229 - $24,781	119 Added 1.26%	9,570 $1.86 Million
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $19,270 - $21,724	104 Added 1.11%	9,451 $1.96 Million
Q2 2018 Jul 10, 2018	BUY	$166.05 - $186.51 $142,803 - $160,398	860 Added 10.13%	9,347 $1.73 Million
Q1 2018 Apr 09, 2018	BUY	$169.43 - $198.0 $7,624 - $8,910	45 Added 0.53%	8,487 $1.45 Million
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $74,773 - $83,545	-443 Reduced 4.99%	8,442 $1.47 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $1.49 Million - $1.7 Million	8,885	8,885 $1.66 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.

Account

First Premier Bank Amgen Inc Transaction History